BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25587935)

  • 1. Oral absorption enhancement of probucol by PEGylated G5 PAMAM dendrimer modified nanoliposomes.
    Ma Q; Han Y; Chen C; Cao Y; Wang S; Shen W; Zhang H; Li Y; van Dongen MA; He B; Yu M; Xu L; Banaszak Holl MM; Liu G; Zhang Q; Qi R
    Mol Pharm; 2015 Mar; 12(3):665-74. PubMed ID: 25587935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
    Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
    J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G5 PAMAM dendrimer versus liposome: a comparison study on the in vitro transepithelial transport and in vivo oral absorption of simvastatin.
    Qi R; Zhang H; Xu L; Shen W; Chen C; Wang C; Cao Y; Wang Y; van Dongen MA; He B; Wang S; Liu G; Banaszak Holl MM; Zhang Q
    Nanomedicine; 2015 Jul; 11(5):1141-51. PubMed ID: 25791813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high-drug-loading self-assembled nanoemulsion enhances the oral absorption of probucol in rats.
    Zhang Z; Huang J; Jiang S; Liu Z; Gu W; Yu H; Li Y
    J Pharm Sci; 2013 Apr; 102(4):1301-6. PubMed ID: 23378294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiatherogenic effects of cilostazol and probucol alone, and in combination in low density lipoprotein receptor-deficient mice fed with a high fat diet.
    Yoshikawa T; Mitani K; Kotosai K; Nozako M; Miyakoda G; Yabuuchi Y
    Horm Metab Res; 2008 Jul; 40(7):473-8. PubMed ID: 18404599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer.
    Fu F; Wu Y; Zhu J; Wen S; Shen M; Shi X
    ACS Appl Mater Interfaces; 2014 Sep; 6(18):16416-25. PubMed ID: 25185074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of probucol on the oral bioavailability of cyclosporine A.
    Sugimoto K; Sudoh T; Tsuruoka S; Yamamoto Y; Maezono S; Watanabe Y; Fujimura A
    Eur J Pharm Sci; 2004 May; 22(1):71-7. PubMed ID: 15113585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization and optimization of probucol self-emulsified drug delivery system to enhance solubility and dissolution.
    Zaghloul A; Khattab I; Nada A; Al-Saidan S
    Pharmazie; 2008 Sep; 63(9):654-60. PubMed ID: 18819518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of caveolin-1 and syndecan-4 in the internalization of PEGylated PAMAM dendrimer polyplexes into myoblast and hepatic cells.
    Shen W; van Dongen MA; Han Y; Yu M; Li Y; Liu G; Banaszak Holl MM; Qi R
    Eur J Pharm Biopharm; 2014 Nov; 88(3):658-63. PubMed ID: 25083608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous and diet-aggravated hemolysis and its correction by probucol in SR-BI knockout mice with LDL-R deficiency.
    Liao J; Gao M; Wang M; Guo X; Huang W; Liu G
    Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):48-53. PubMed ID: 25983325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biological effects of the hypolipidaemic drug probucol microcapsules fed daily for 4 weeks, to an insulin-resistant mouse model: potential hypoglycaemic and anti-inflammatory effects.
    Mooranian A; Negrulj R; Takechi R; Mamo J; Al-Sallami H; Al-Salami H
    Drug Deliv Transl Res; 2018 Jun; 8(3):543-551. PubMed ID: 29313296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of plasma cholesterol-lowering action of probucol with various lipid carrier systems.
    Takino T; Koreeda N; Nomura T; Sakaeda T; Yamashita F; Takakura Y; Hashida M
    Biol Pharm Bull; 1998 May; 21(5):492-7. PubMed ID: 9635506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
    Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting hepatic cancer cells with pegylated dendrimers displaying N-acetylgalactosamine and SP94 peptide ligands.
    Medina SH; Tiruchinapally G; Chevliakov MV; Durmaz YY; Stender RN; Ensminger WD; Shewach DS; Elsayed ME
    Adv Healthc Mater; 2013 Oct; 2(10):1337-50. PubMed ID: 23554387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directed self-assembled nanoparticles of probucol improve oral delivery: fabrication, performance and correlation.
    Zhang Z; Jiang S; Liu Z; Niu B; Gu W; Li Y; Cui J
    Pharm Res; 2014 Sep; 31(9):2266-75. PubMed ID: 24590879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a tertiary bile acid, taurocholic acid, on the morphology and physical characteristics of microencapsulated probucol: potential applications in diabetes: a characterization study.
    Mooranian A; Negrulj R; Arfuso F; Al-Salami H
    Drug Deliv Transl Res; 2015 Oct; 5(5):511-22. PubMed ID: 26242686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probucol Protects Against Atherosclerosis Through Lipid-lowering and Suppressing Immune Maturation of CD11c+ Dendritic Cells in STZ-induced Diabetic LDLR-/- Mice.
    Zhu H; Jin X; Zhao J; Dong Z; Ma X; Xu F; Huang W; Liu G; Zou Y; Wang K; Hu K; Sun A; Ge J
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):620-7. PubMed ID: 25714599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree.
    Prego C; Torres D; Fernandez-Megia E; Novoa-Carballal R; Quiñoá E; Alonso MJ
    J Control Release; 2006 Apr; 111(3):299-308. PubMed ID: 16481062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic transport of orally administered probucol-loaded mPEG-DSPE micelles.
    Han L; Yang Q; Shen T; Qing J; Wang J
    Drug Deliv; 2016 Jul; 23(6):1955-61. PubMed ID: 25816053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probucol and cilostazol exert a combinatorial anti-atherogenic effect in cholesterol-fed rabbits.
    Chen Y; Zhao S; Huang B; Wang Y; Li Y; Waqar AB; Liu R; Bai L; Fan J; Liu E
    Thromb Res; 2013 Nov; 132(5):565-71. PubMed ID: 24090606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.